177 related articles for article (PubMed ID: 10461100)
21. Aqueous ethanolic extract of St. John's wort (Hypericum perforatum L.) induces growth inhibition and apoptosis in human malignant cells in vitro.
Hostanska K; Reichling J; Bommer S; Weber M; Saller R
Pharmazie; 2002 May; 57(5):323-31. PubMed ID: 12061257
[TBL] [Abstract][Full Text] [Related]
22. Seasonal variation in hypericin content of Hypericum perforatum L. (St. John's Wort).
Southwell IA; Bourke CA
Phytochemistry; 2001 Mar; 56(5):437-41. PubMed ID: 11261576
[TBL] [Abstract][Full Text] [Related]
23. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
Butterweck V; Winterhoff H; Herkenham M
Mol Psychiatry; 2001 Sep; 6(5):547-64. PubMed ID: 11526469
[TBL] [Abstract][Full Text] [Related]
24. Determination of total hypericins in St. John's wort and herbal medicinal products.
Anyzewska M; Kowalczuk A; Łozak A; Jabłczyńska R; Fijałek Z
Acta Pol Pharm; 2010; 67(6):586-92. PubMed ID: 21229872
[TBL] [Abstract][Full Text] [Related]
25. Determination of naphthodianthrones and phloroglucinols from Hypericum perforatum extracts by liquid chromatography/tandem mass spectrometry.
Tolonen A; Uusitalo J; Hohtola A; Jalonen J
Rapid Commun Mass Spectrom; 2002; 16(5):396-402. PubMed ID: 11857723
[TBL] [Abstract][Full Text] [Related]
26. Effect of light on hypericins contents in fresh flowering top parts and in an extract of St. John's Wort (Hypericum perforatum).
Poutaraud A; Di Gregorio F; Tin VC; Girardin P
Planta Med; 2001 Apr; 67(3):254-9. PubMed ID: 11345698
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous determination of hypericin and hyperforin in human plasma and serum using liquid-liquid extraction, high-performance liquid chromatography and liquid chromatography-tandem mass spectrometry.
Pirker R; Huck CW; Bonn GK
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Sep; 777(1-2):147-53. PubMed ID: 12270208
[TBL] [Abstract][Full Text] [Related]
28. The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: a beneficial "side effect" of an OTC antidepressant drug?
Laggner H; Schreier S; Hermann M; Exner M; Mühl A; Gmeiner BM; Kapiotis S
Free Radic Res; 2007 Feb; 41(2):234-41. PubMed ID: 17364950
[TBL] [Abstract][Full Text] [Related]
29. Rapid and efficient purification of naphthodianthrones from St. John's wort extract by using liquid-liquid extraction and SEC.
Karioti A; Vincieri FF; Bilia AR
J Sep Sci; 2009 May; 32(9):1374-82. PubMed ID: 19360729
[TBL] [Abstract][Full Text] [Related]
30. Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test.
Butterweck V; Petereit F; Winterhoff H; Nahrstedt A
Planta Med; 1998 May; 64(4):291-4. PubMed ID: 9619107
[TBL] [Abstract][Full Text] [Related]
31. Plasma pharmacokinetics and cerebrospinal fluid penetration of hypericin in nonhuman primates.
Fox E; Murphy RF; McCully CL; Adamson PC
Cancer Chemother Pharmacol; 2001; 47(1):41-4. PubMed ID: 11221960
[TBL] [Abstract][Full Text] [Related]
32. An in vitro and hydroponic growing system for hypericin, pseudohypericin, and hyperforin production of St. John's wort (Hypericum perforatum CV new stem).
Murch SJ; Rupasinghe HP; Saxena PK
Planta Med; 2002 Dec; 68(12):1108-12. PubMed ID: 12494339
[TBL] [Abstract][Full Text] [Related]
33. Discovery of key regulators of dark gland development and hypericin biosynthesis in St. John's Wort (Hypericum perforatum).
Rizzo P; Altschmied L; Stark P; Rutten T; Gündel A; Scharfenberg S; Franke K; Bäumlein H; Wessjohann L; Koch M; Borisjuk L; Sharbel TF
Plant Biotechnol J; 2019 Dec; 17(12):2299-2312. PubMed ID: 31037808
[TBL] [Abstract][Full Text] [Related]
34. Plasma levels of hypericin in presence of procyanidin B2 and hyperoside: a pharmacokinetic study in rats.
Butterweck V; Liefländer-Wulf U; Winterhoff H; Nahrstedt A
Planta Med; 2003 Mar; 69(3):189-92. PubMed ID: 12677519
[TBL] [Abstract][Full Text] [Related]
35. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
Vacek J; Klejdus B; Kubán V
Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
[TBL] [Abstract][Full Text] [Related]
36. Acute effects of LI 160 (extract of Hypericum perforatum, St John's wort) and two of its constituents on neuroendocrine responses in the rat.
Franklin M; Chi JD; Mannel M; Cowen PJ
J Psychopharmacol; 2000; 14(4):360-3. PubMed ID: 11198053
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological and endocrine effects of Hypericum perforatum and hypericin after repeated treatment.
Butterweck V; Korte B; Winterhoff H
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S2-7. PubMed ID: 11518068
[TBL] [Abstract][Full Text] [Related]
38. Final report on the safety assessment of Hypericum perforatum extract and Hypericum perforatum oil.
Int J Toxicol; 2001; 20 Suppl 2():31-9. PubMed ID: 11558639
[TBL] [Abstract][Full Text] [Related]
39. Effects of UV-B on secondary metabolites of St. John's Wort (Hypericum perforatum L.) grown in controlled environments.
Brechner ML; Albright LD; Weston LA
Photochem Photobiol; 2011; 87(3):680-4. PubMed ID: 21275996
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.
Obach RS
J Pharmacol Exp Ther; 2000 Jul; 294(1):88-95. PubMed ID: 10871299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
